ZACCARDELLI DAVID 4
4 · SAB Biotherapeutics, Inc. · Filed Jan 7, 2026
Insider Transaction Report
Form 4
ZACCARDELLI DAVID
Director
Transactions
- Award
Stock Option (right to buy)
2026-01-05+240,000→ 240,000 totalExercise: $3.74Exp: 2036-01-05→ Common Stock (240,000 underlying)
Footnotes (2)
- [F1]Represents the inaugural grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in three equal annual installments on January 5, 2027, January 5, 2028 and January 5, 2029.
- [F2]This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.